Neurobehavioral Manifestations
29
4
4
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.9%
2 terminated out of 29 trials
90.9%
+4.4% vs benchmark
10%
3 trials in Phase 3/4
25%
5 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (29)
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
NiPPeR Randomised Trial - Child Follow Up Study
NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood
A Trial of Metformin in Individuals With Fragile X Syndrome
Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months
Dopaminergic Therapy for Frontotemporal Dementia Patients
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation
Rett Syndrome Registry
Measuring Brain Activity of School Age Children
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
A Software to Prevent Delirium (PREVEDEL) in Hospitalized Older Adults
Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study)
Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures
Residual Effects of Intoxication on Student Performance
Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development
The Effect of Case Conferencing in Nursing Homes
Scalp Application of LED Therapy to Improve Thinking and Memory in Veterans With Gulf War Illness
Neuroimaging During Pure Oxygen Breathing